EU Approves Pfizer’s COVID-19 Vaccine for Ages 5 to 11
- Date: 26-Nov-2021
- Source: Nasdaq
- Sector:Healthcare
- Country:Saudi Arabia
EU Approves Pfizer’s COVID-19 Vaccine for Ages 5 to 11
Pfizer Inc. (PFE) and BioNTech SE’s (BNTX) COVID-19 vaccine received approval from the European Union’s regulatory authority for children between the ages of 5 and 11.
The approval will in aid the mitigation of the accelerated rise in COVID-19 cases in Europe. Shares closed at $50.89 on November 25.
According to Reuters, the European Medicines Agency (EMA) has approved the vaccine, Comirnaty, as an injection (in the upper arm) in two 10 microgram doses, to be administered three weeks apart .
Select Sector 
Select Country 
